Wolfgang Trillo Álvarez, MD PROF, Gabriel A Calderón Paiva, Med Student, Joshua A Medina Suárez, Med Student, Juan I.S. Valdivia Pino, Med Student, Patrick F Gonzales Romero, Med Student, Luis J Delgado Villanueva, Med Student, Angélica M Flores Quispe, Med Student, Grace N García Huaman, Med Student, Pedro G Chirinos Mamani, Med Student and Zelitt Del Castillo Carrasco, Med Student, Human Medicine, SINAPSIS-UCSM, Arequipa, Peru

A. Suzanne Boyd, PhD, MSW, ACSW, FNAP, School of Social Work, University of North Carolina at Charlotte, Charlotte, NC and Research Team

Albert Aboseif, DO1, Moein Amin, MD2, Gabrielle Macaron, MD2 and Daniel Ontaneda, MD PhD2, (1)Department of Neurology, Cleveland Clinic, Cleveland, OH, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

Afolasade Fakolade, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, Adam Groh, M.Sc., The Montreal Neurological Institute and Hospital, Montreal, QC, Canada, Colleen Lacey, M.Sc., Psychology, University of Victoria, Victoria, BC, Canada; Institute on Aging and Lifelong Health, Victoria, BC, Canada and Fiona Tea, Ph.D., The Research Centre of the University of Montreal Hospital Centre (CRCHUM), Montreal, QC, Canada

Shuvro Roy, MD, Janel Haughton, RN and Scott D Newsome, DO, MSCS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Gabrielle Busque, BSc, PharmD, ACPR1, Henry Halapy, BScPhm, ACPR, PharmD1, Sharan Lail, BScPhm, ACPR, PharmD1 and Norman Dewhurst, BScPhm, ACPR, PharmD, MHSc2, (1)Pharmacy, Unity Health Toronto, Toronto, ON, Canada, (2)Ambulatory Clinics, Emergency and Medicine Program, Unity Health Toronto, Toronto, ON, Canada

Katherine Gwin, RN, BSN, MSCS, MSCN, Kaelianne Newbold, RN, BSN, MSCS, MSCN, Autumn Ramsrud, PharmD, CSP, MSCS, Tyler Cress, PharmD, MSCS, Cindy Smith, PharmD, CSP, Angie Critchfield, CPhT and Nina Bozinov, MD, MS, Neurology, Kootenai Clinic, Coeur d’Alene, ID

Dotty Holcomb Doherty, N/A1, Nicole Delcourt, RN1, Ann Cabot, DO2 and Brant J. Oliver, PhD, MS, MPH, APRN-BC3, (1)Multiple Sclerosis Specialty Care Program, Concord Hospital, Concord, NH, (2)Multidisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH, (3)Community of Family and Medicine, Dartmouth Health, Lebanon, NH

Emily Blosberg, BS and Andrea Blosberg, BA, MA, Mr Oscar Monkey, Menomonie, WI

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Aportela, I., Barnola, A., Benson, T., Cohrs, R., Cummings, S., Doherty, E., Fegan, A., Goff, K., Liserio, E., Mastroianni, S., Marshall, J., Saxton, L., Serratoni, M., Stewart, K., Tauchman, J., Wiehardt, G., Wise, J.

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Benson, T., Bostick, M., Goff, K., Henderson, L. Liserio, E., Nearhood, H., Saxton, L., Tauchman, J., Yadav, V., Zackowski, K

Lily Martinez, MPH, The National Multiple Sclerosis Society, Dallas, TX, Thaís Armangué, MD, PhD, Sant Joan de Deu, Barcelona Hospital, Barcelona, Spain, Brenda Banwell, MD, FRCPC, FAAN, The Children’s Hospital of Philadelphia, Philadelphia, PA, Frederik Barkhof, MD, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, Jennifer Graves, MD, PhD, MAS, University of California San Diego, San Diego, CA, Cheryl Hemingway, MBChB, PhD, Great Ormond Street Children’s Hospital, London, United Kingdom, Barbara Kornek, MD, Medical University of Vienna, Vienna, Austria, Hope Nearhood, MPH, The National Multiple Sclerosis Society, Denver, CO, Lekha Pandit, MD, DM, PhD, Nitte University, Karnataka, India and Darren Ball, M.Ed., The National Multiple Sclerosis Society, New York, NY

Michael V Robers, MD MS1, Vanessa I Martinez, MS1, Hollie Schmidt, MS2, Patricia Teran, MS1, Tiffany Tran, BS1, Huiam Mubarak, MD MS1, Aimee Borazanci, MD1 and Lilyana Amezcua, MD, MS3, (1)Neurology, Barrow Neurological Institute, Phoenix, AZ, (2)Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, (3)Keck School of Medicine, University of Southern California, Los Angeles, CA

Rae Bacharach, DO1, Jikku Zachariah, DO1, Benjamin Bird, MD1 and Elizabeth Sinz, MD2, (1)Neurology, Penn State Milton S. Hershey Medical Center, Hershey, PA, (2)Anesthesiology, Critical Care Medicine, and Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA

Mirla Avila, MD, Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, Martin Sandoval, student, Texas Tech Health science center, Lubbock, TX and Hannah Jackson, student, Texas Tech health science center, Lubbock, TX

Kristen Veal, MD1, Elijah Lackey, MD1 and Suma Shah, MD2, (1)MS and Neuroimmunology, Duke University Hospital, Durham, NC, (2)Department of Neurology, Duke University, Durham, NC

Stephanie Gandelman, MD, Laura Stein, MD, MSEd and Dina Jacobs, MD, Department of Neurology, University of Pennsylvania, Philadelphia, PA

Andrew M Tarr, MD1,2, Nadia Azad, BS3, Christina Fournier, MD1,2 and William Tyor, MD1,2, (1)Neurology, Atlanta VA Medical Center, Decatur, GA, (2)Neurology, Emory University, Atlanta, GA, (3)School of Medicine, Emory University, Atlanta, GA

Paul S. Giacomini, MD1, Natacha Bastien, Ph.D.2, Patrice Voss, Ph.D.3, Francois Blanchette, Ph.D.2, Francis Arseneau, Ms3, Shamiza Hussein, PMP2, Rosemberg Ramos, Ms3 and Etienne de Villers-Sidani, MD3, (1)Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (2)Medical Affairs, Novartis Pharma Canada, Dorval, QC, Canada, (3)Innodem Neurosciences, Montreal, QC, Canada

Sara Esmaeili, Research Fellow, Neurology, University of Cincinnati, Cincinnati, OH and Aram Zabeti, MD, Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH

Elina Misicka, Ph.D, Case Western Reserve University, Cleveland, OH and Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH

Adrian Kielhorn, BA1, Jacqueline Palace, DM2, Nina Eagle, MS2, M Isabel Leite, MS2, Lauren Powell, BSc, MSc, PhD3 and Karissa Johnston, BSc, MSc, PhD3, (1)Alexion, AstraZeneca Rare Disease, Boston, MA, (2)Oxford University Hospital, Oxford, United Kingdom, (3)BroadStreet Health Economics & Outcomes Research, Vancouver, BC, Canada

Alexander J Gill, MD, PhD, Marjan Gharagozloo, PhD, Thomas Garton, B.S., Matt Smith, M.S. and Peter A Calabresi, MD, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Austin Chen, MD1, Francesca Chinea, BA2, Gary Cutter, PhD3, Lauren Krupp, MD1, Ilya Kister, MD1, Lana Zhovtis Ryerson, M.D.1 and Tyler E Smith, M.D.1, (1)Neurology, NYU Langone Health, New York, NY, (2)NYU, New York, NY, (3)University of Alabama School of Public Health, Birmingham, AL

Evanthia Bernitsas, MD1, Benjamin Osborne, MD2, Natalie Taylor, MPH3, Fanyang Zeng, MPH3, Milena Anatchkova, PhD3 and Adrian Kielhorn, BA4, (1)Wayne State University School of Medicine, Detroit, MI, (2)Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, (3)Evidera, Bethesda, MD, (4)Alexion, AstraZeneca Rare Disease, Boston, MA

Jacob A Cuevas, B.S.1, Alexandru Tatomir, MD1, Vinh Nguyen, DMD2, Tudor Badea, MD/PhD3, Violeta Rus, MD/PhD2 and Horea Rus, MD, PhD4, (1)Neurology, University of Maryland, Baltimore, MD, (2)Medicine, University of Maryland, Baltimore, MD, (3)Research and Development Institute, Transylvania University of Brasov, Brasov, Romania, (4)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

Jin Nakahara, MD, PhD1, Ichiro Nakashima, MD, PhD2, Hiroaki Yokote, MD3, Yasuhiro Manabe, MD4, Kazumi Okamura, MD5, Kou Hasegawa, PhD5 and Kazuo Fujihara, MD6,7, (1)Department of Neurology, Keio University School of Medicine, Tokyo, Japan, (2)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (3)Department of Neurology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan, (4)Department of Neurology, National Hospital Organization Okayama Medical Center, Okayama, Japan, (5)Alexion Pharma GK, Tokyo, Japan, (6)Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (7)Fukushima Medical University School of Medicine, Fukushima, Japan

Kerstin Allen, MA1, Sean J Pittock, MD2, Michael Levy, MD, PhD3, Jacqueline Palace, DM4, Celia Oreja-Guevara, MD5,6, Ichiro Nakashima, MD, PhD7,8, Achim Berthele, MD9, Jeffrey L Bennett, MD, PhD10, Jerome de Seze, MD, PhD11, Michael Barnett, PhD, MD12,13, Friedemann Paul, MD14, Carlo Pozzilli, MD, PhD15, Yasmin Mashhoon, PhD1, Marcus Yountz, MD1 and Ho Jin Kim, MD16, (1)Alexion, AstraZeneca Rare Disease, Boston, MA, (2)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (3)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (4)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (5)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (6)Hospital Clinico San Carlos, Madrid, Spain, (7)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (8)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (9)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (10)University of Colorado School of Medicine, Aurora, CO, (11)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (12)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (13)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (14)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (15)NCL Institute of Neurological Science, Rome, Italy, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

Bruce A.C. Cree, MD1, Mary Rensel, MD2, Sean J Pittock, MD3, Aram Zabeti, MD4, Ho-Jin Kim, MD5, Friedemann Paul, MD6, Derrick S Robertson, MD7, Kristina R Patterson, MD, PhD8, Qing Li, MD, PhD9, Quinn Dinh, MD9 and Michael Levy, MD, PhD10, (1)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Neurology, Cleveland Clinic, Cleveland, OH, (3)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (4)Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH, (5)Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (6)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (7)Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, (8)Horizon Therapeutics, Deerfield, IL, (9)Horizon Therapeutics plc, Deerfield, IL, (10)Massachusetts General Hospital and Harvard Medical School, Boston, MA

Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA1,2,3,4, Brian G Weinshenker, MD5, Sean J Pittock, MD6, Jeffrey L Bennett, MD, PhD7, Michael A Smith, PhD8, Nanette Mittereder, MS8, William A Rees, PhD8, Daniel Cimbora, PhD8, Kristina R Patterson, MD, PhD8, Friedemann Paul, MD9, Romain Marignier, MD10, Dean M Wingerchuk, MD11, Gary Cutter, MS, PhD12, Ari Green, MD13, Ho-Jin Kim, MD14, Kazuo Fujihara, MD15,16, Michael Levy, MD, PhD17, Orhan Aktas, MD18 and Bruce A.C. Cree, MD19, (1)Department of Neurology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (2)Brain and Mind Centre, University of Sydney, Sydney, Australia, (3)Department of Neurology, Medical University Vienna, Vienna, Austria, (4)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (5)Department of Neurology, University of Virginia, Charlottesville, VA, (6)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (7)University of Colorado School of Medicine, Aurora, CO, (8)Horizon Therapeutics, Deerfield, IL, (9)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (10)Department of Neurology, MS, Myelin Pathologies, and Neuroinflammation, Lyon University Hospital, Lyon, France, (11)Department of Neurology, Mayo Clinic, Scottsdale, AZ, (12)Department of Biostatistics, UAB School of Public Health, Birmingham, AL, (13)Department of Neurology and Department of Ophthalmology, UCSF Weill Institute for Neurosciences, San Francisco, CA, (14)Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (15)Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (16)Fukushima Medical University School of Medicine, Fukushima, Japan, (17)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (18)Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany, (19)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA

Pavle Repovic, MD, PhD1, Jongchan Choi, PhD2, Sunga Hong, PhD2, Lik W Lee, PhD3, Darcy B. Gill, PhD3, James D. Bowen, MD1, Peiqing Qian, MD1, Simon Evans, PhD2, Rick Edmark, PhD2, Jason P. Mendoza, PhD4, Robin L. Avila, PhD4, Jim Heath, PhD2 and Jason Goldman, MD, MPH5, (1)Swedish Neuroscience Institute, Seattle, WA, (2)Institute for Systems Biology, Seattle, WA, (3)Adaptive Biotechnologies, Seattle, WA, (4)Biogen, Cambridge, MA, (5)Swedish Medical Center, Seattle, WA

Sean J Pittock, MD1, Michael Barnett, PhD, MD2,3, Jeffrey L Bennett, MD, PhD4, Achim Berthele, MD5, Jerome de Seze, MD, PhD6, Michael Levy, MD, PhD7, Ichiro Nakashima, MD, PhD8,9, Celia Oreja-Guevara, MD10,11, Jacqueline Palace, DM12, Friedemann Paul, MD13, Carlo Pozzilli, MD, PhD14, Kerstin Allen, MA15, Yasmin Mashhoon, PhD15, Marcus Yountz, MD15 and Ho Jin Kim, MD16, (1)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (2)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (4)University of Colorado School of Medicine, Aurora, CO, (5)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (6)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (7)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (8)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (9)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (10)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (11)Hospital Clinico San Carlos, Madrid, Spain, (12)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (13)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (14)Department of Human Neuroscience, La Sapienza University, Rome, Italy, (15)Alexion, AstraZeneca Rare Disease, Boston, MA, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

Sean J Pittock, MD1, Michael Barnett, PhD, MD2,3, Jeffrey L Bennett, MD, PhD4, Achim Berthele, MD5, Jerome de Seze, MD, PhD6, Michael Levy, MD, PhD7, Ichiro Nakashima, MD, PhD8,9, Celia Oreja-Guevara, MD10,11, Jacqueline Palace, DM12, Friedemann Paul, MD13, Carlo Pozzilli, MD, PhD14, Kerstin Allen, MA15, Yasmin Mashhoon, PhD15, Marcus Yountz, MD15 and Ho Jin Kim, MD16, (1)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (2)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (4)University of Colorado School of Medicine, Aurora, CO, (5)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (6)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (7)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (8)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (9)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (10)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (11)Hospital Clinico San Carlos, Madrid, Spain, (12)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (13)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (14)NCL Institute of Neurological Science, Rome, Italy, (15)Alexion, AstraZeneca Rare Disease, Boston, MA, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

Shlok Sarin, BS1, Nikhil Modak, MD2, Rongyi Sun, BS3, Omar Subei, MD4, Alessandro Serra, MD, PhD5, Michael Morgan, MD, PhD6 and Hesham Abboud, MD, PhD3, (1)Case Western Reserve School of Medicine – – Cleveland Heights, OH, Cleveland, OH, (2)University Hospitals of Cleveland, Cleveland, OH, (3)Case Western Reserve University School of Medicine, Cleveland, OH, (4)Duke University Medical Center, Durham, NC, (5)Multiple Sclerosis and Neuroimmunology program, University Hospitals Cleveland Medical Center, Cleveland, OH, (6)University Hospitals Cleveland Medical Center, Cleveland, OH

Sean J Pittock, MD, Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, Achim Berthele, MD, Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, Michael Levy, MD, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, MA, Ichiro Nakashima, MD, PhD, Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Celia Oreja-Guevara, MD, Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain; Hospital Clinico San Carlos, Madrid, Spain, Stephan Ortiz, Ph.D., Alexion, AstraZeneca Rare Disease, Boston, MA and Ho Jin Kim, MD, Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

Gauruv Bose, MD1,2, Nupur Greene, PhD, MPH, BPharm3, Brian C. Healy, PhD1, Howard L. Weiner, MD4,5, Lisa Farnett, PharmD3, Keiko Higuchi, MPH3 and Tanuja Chitnis, MD5,6, (1)Brigham and Women’s Hospital, Boston, MA, (2)Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Sanofi, Cambridge, MA, (4)Brigham and Women’s Hospital, Boston, MA, (5)Harvard Medical School, Boston, MA, (6)Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7 and Sarah A Raskin, PhD8,9, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT

Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Jodie Haselkorn, MD, MPH4,5,6,8 and Sarah A Raskin, PhD9,10, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Epidemiology, University of Washington, Seattle, WA, (9)Neuroscience Program, Trinity College, Hartford, CT, (10)Department of Psychology, Trinity College, Hartford, CT

Petra Šili?, BS1, Danielle C Jones, MPH2, Brenda Jeng, Ph.D1 and Robert W. Motl, PhD1, (1)Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, (2)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

Sanghamithra Ramani, BSc1,2, Jordan D. Pumphrey, BSc2,3, Jason A. Berard, PhD4, Matthew Seegobin, MSc.2, Jing Wang, PhD2,4, Jennifer M Lymer, PhD, MD5 and Lisa A.S. Walker, PhD, C. Psych1,2,3,4, (1)Psychology, Carleton University, Ottawa, ON, Canada, (2)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Psychology, University of Ottawa, Ottawa, ON, Canada, (4)University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada, (5)University of Ottawa, Ottawa, ON, Canada